Furthermore, analysis of the data obtained in our study, expressed as the area under the curve, indicates that the levels of Dkk1, TGF-β1, and IL-17A have a sufficiently high sensitivity and specificity to reasonably predict the use of biologics in these patients within 5 years of the onset of arthritis. Here, IL17A is linked to arthritic joint disease.